🇺🇸 FDA
Patent

US 7271161

Platinum complexes as antitumor agents in combination with biochemical modulation

granted A61PA61P35/00A61P43/00

Quick answer

US patent 7271161 (Platinum complexes as antitumor agents in combination with biochemical modulation) held by The Board of Regents of the University of Texas System expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61P, A61P35/00, A61P43/00